Clin2
NCT06948214Possibly a fitRecruiting

LUM-201 for growth hormone deficiency in children

Growth Hormone Deficiency (GHD)

Treatments studied

Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.

This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
150 people
Ages
3 years to 11 years
Study type
Interventional

Who can take part

  • You have not had any growth hormone treatment before and have not started puberty
  • Your height is much shorter than average for your age and gender (at least 2 standard deviations below)
  • Your growth over the past 6 months has been slower than 75% of kids your age and gender
  • Your bone age (how mature your skeleton is) is at least 1 year behind your actual age
  • Your IGF-1 level is low (a sign of growth hormone deficiency)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07129759Not yet recruiting· Phase 3
Long-term safety of LUM-201 in children with growth hormone deficiency

This study looks at the long-term safety of the medicine LUM-201, which helps children with growth hormone deficiency (a condition where the body doesn't make enough growth hormone, so growth is slower than normal). It is a follow-up for children who already completed the first year of the main study, to see if continuing the medicine is safe over a longer time.

NCT07553351Recruiting· Phase 3
Growth hormone treatment for children with growth hormone deficiency

This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.

Chengdu, Sichuan
NCT07126288Not yet recruiting· Phase 2/Phase 3
A new daily injection for children with growth hormone deficiency

This trial tests a new growth hormone injection (GB08) to see if it helps children with growth hormone deficiency grow taller. If your child is diagnosed with this condition and hasn't yet tried growth hormone treatment, they might benefit from participating.

Xiamen, Fujian
NCT05796440Enrolling by invitation· Phase 2
Long-term safety study of LUM-201 in children with growth hormone deficiency

This trial checks the long-term safety of LUM-201 in children who have idiopathic growth hormone deficiency and already completed an earlier LUM-201 study. If you previously took LUM-201 and are allowed to continue, the study may help your care team monitor ongoing effects over time.

Iowa City, Iowa
NCT07450053Not yet recruiting· Phase 1/Phase 2
Growth hormone treatment for children with short stature

This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.

Wuhan, Hubei
NCT07264595Recruiting· Phase 1/Phase 2
Study of GS3-007a for children with growth hormone deficiency

This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.

Wuhan, Hubei

Hear when a new Growth Hormone Deficiency (GHD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.